COMMUNIQUÉS West-GlobeNewswire

Sunesis Pharmaceuticals Announces Cancellation of Presentation and Webcast at Cowen & Company 38th Annual Health Care Conference

13/03/2018 - 12:00

Cancellation due to Travel Changes Caused by Inclement Weather Management to Proceed with Scheduled Investor Meetings via Conference Calls SOUTH SAN FRANCISCO, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Sunesis [...]

Tonix Pharmaceuticals to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

13/03/2018 - 12:00

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), announced today that it will present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering [...]

Melinta Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

13/03/2018 - 12:00

Baxdela ™ (delafloxacin) Launched February 6, 2018, in U.S. for Adults with ABSSSI Acquired Infectious Disease Business from The Medicines Company on January 5, 2018 First Earnings Report as a Public Company NEW HAVEN, [...]

Affimed Announces Fourth Quarter and Year End 2017 Financial Results and Corporate Update Conference Call

13/03/2018 - 11:00

Heidelberg, Germany, March 13, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that on March [...]

PotNetwork Holding To Enter World’s Fastest Growing Market With Formation Of Blockchain Crypto Technology Subsidiary

13/03/2018 - 11:00

FT LAUDERDALE, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding Inc. (OTC Pink:POTN) (“Company”), announced today that after considerable evaluation and planning, the Company enters into [...]

Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration

13/03/2018 - 11:00

Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated development of MultiStem [...]

United Health Products Receives CE Mark Approval for HemoStyp®

13/03/2018 - 10:30

Henderson, Nev., March 13, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

Final transactions in relation to share buyback program

13/03/2018 - 08:43

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Ossur Hf : Share buy-back of 1,478,700 own shares

13/03/2018 - 08:30

Announcement no. 21/2018 Reykjavik, 13 March 2018 Share buy-back of 1,478,700 own shares Today, Össur purchased 1,478,700 own shares at the price of DKK 28.10 per share. The total purchase price amounted to DKK 41.55 [...]

PCI Biotech: Invitation to full year 2017 presentation

13/03/2018 - 08:01

Oslo, 13 March 2018 - PCI Biotech invites to a presentation of the company's full year 2017 report on Tuesday 20 March 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday March 20, 08:30am - 09:30am CET (local [...]

Athersys and Healios Announce Binding Letter of Intent to Expand MultiStem® Collaboration

13/03/2018 - 07:30

Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated development of MultiStem [...]

UPDATE -- Immuron Commences US Non-Deal Institutional Investor Roadshow

13/03/2018 - 07:15

MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC)(NASDQ:IMRN) is pleased to release to shareholders and investors its latest Company [...]

Kiadis Pharma N. V.: Kiadis Pharma raises €23.4 million in a private placement of 2.6 million new shares

13/03/2018 - 07:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION [...]

Gallup and Sharecare Announce Annual Community Rankings

13/03/2018 - 05:01

ATLANTA, March 13, 2018 (GLOBE NEWSWIRE) -- Sharecare , the digital health company that helps people manage all their health in one place, and world-leading analytics and advice firm, Gallup , today reported their [...]

MediciNova to Participate in Business Development Panel Session at the BIO Asia International Conference in Tokyo

13/03/2018 - 00:00

LA JOLLA, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875 [...]

Genocea Appoints Narinder Singh as SVP Pharmaceutical Sciences & Manufacturing

12/03/2018 - 22:39

CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced the appointment of Narinder Singh as [...]

Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program

12/03/2018 - 21:34

Single dose of vaccine showed 67% survival rate and 100% survival rate after two doses GAITHERSBURG, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, [...]

ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017

12/03/2018 - 21:30

ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017 Conference call and webcast on Tuesday, March 13 th at 1:30 pm CET/8:30 am EDT Reported positive data from Phase 2b clinical trial of [...]

Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipids and Inflammatory Markers in Patients With Persistent High Triglycerides and Elevated High-Sensitivity C-Reactive Protein (hsCRP)

12/03/2018 - 21:30

BEDMINSTER, N.J. and DUBLIN, Ireland, March 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]